Background-Although adiposity is increasingly recognized as a risk factor for atrial fibrillation (AF), the importance of epicardial fat compared with other adipose tissue depots remains uncertain. We sought to characterize and compare the associations of AF with epicardial fat and measures of abdominal and overall adiposity. Methods and Results-We conducted a meta-analysis of 63 observational studies including 352 275 individuals, comparing AF risk for 1-SD increases in epicardial fat, waist circumference, waist/hip ratio, and body mass index. A 1-SD higher epicardial fat volume was associated with a 2.6-fold higher odds of AF (odds ratio, 2.61; 95% confidence interval [CI], 1.89-3.60), 2.1-fold higher odds of paroxysmal AF (odds ratio, 2.14; 95% CI, 1.45-3.16) and, 5.4-fold higher odds of persistent AF (odds ratio, 5.43; 95% CI, 3.24-9.12) compared with sinus rhythm. Likewise, a 1-SD higher epicardial fat volume was associated with 2.2-fold higher odds of persistent compared with paroxysmal AF (odds ratio, 2.19; 95% CI, 1.66-2.88). Similar associations existed for postablation, postoperative, and postcardioversion AF. In contrast, associations of abdominal and overall adiposity with AF were less extreme, with relative risks per 1-SD higher values of 1.32 (95% CI, 1.25-1.41) for waist circumference, 1.11 (95% CI, 1.08-1.14) for waist/hip ratio, and 1.22 (95% CI, 1.17-1.27) for body mass index. Conclusions-Strong and graded associations were observed between increasing epicardial fat and AF. Moreover, the strength of associations of AF with epicardial fat is greater than for measures of abdominal or overall adiposity. Further studies are needed to assess the mechanisms and clinical relevance of epicardial fat. (Circ Arrhythm Electrophysiol. 2016;9:e004378.
O besity is increasingly recognized as an important and modifiable determinant of atrial fibrillation (AF), which is the most common cardiac arrhythmia. [1] [2] [3] [4] [5] However, the mechanisms through which obesity causes AF are not fully understood. Previous studies have demonstrated that obesity is associated with diastolic dysfunction, atrial inflammation, myocardial lipidosis, and atrial contractile dysfunction. [6] [7] [8] [9] [10] Such changes may result in atrial structural remodeling (including diffuse atrial fibrosis and dilatation), and electrophysiological abnormalities (including conduction slowing and shortened atrial effective refractory periods). 7, 8 It is possible that these changes may contribute to an arrhythmogenic atrial substrate that promotes AF.
Epicardial fat, an ectopic adipose tissue, is a metabolically active tissue that produces cytokines and chemokines that may enhance atrial arrhythmogenesis. Previous studies have suggested that biomarkers of inflammation (including interleukin-1β, tumor necrosis factor-α) may promote atrial fibrosis via paracrine effects on the adjacent myocardium and cause microreentry circuits via fatty infiltration that interrupt conduction wavefronts. 11, 12 Population studies have also demonstrated independent associations of epicardial fat with atrial conduction properties. 13 Although associations between epicardial fat and AF have been reported, suggesting that epicardial fat may mediate the relationship between overall adiposity and AF, the results of individual studies have not been entirely consistent.
14-17 Hence, we conducted a meta-analysis of all observational studies reporting associations between epicardial fat and AF to clarify the strength of the associations between epicardial fat with AF, to determine the extent to which these associations vary in different clinical settings, and to explore any reasons for between-study heterogeneity. Moreover, we compared the strength of the associations of AF with other measures of adiposity, including abdominal and overall adiposity.
Methods
This systematic review and meta-analysis was performed in accordance with both the MOOSE (Meta-Analysis of Observational Studies in Epidemiology) and STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines.
Search Strategy and Eligibility Criteria
We performed a systematic search of observational studies in MEDLINE and EMBASE databases available to July 2015. This search was supplemented by manual hand-searching of the reference lists from individual studies, review articles, and conference proceedings. Search terms included epicardial, pericardial, fat, adipose, ectopic, visceral, body mass index (BMI), waist circumference (WC), waist-hip ratio, waist-to-hip ratio (WHR), AF, and their combinations. Studies were included if they were cross-sectional, case-control, or cohort studies that allowed for an assessment of associations between continuous measures of adiposity (epicardial fat, pericardial fat, WC, WHR, or BMI) and AF risk. We also included studies reporting data that allowed for an assessment of associations of epicardial fat with the severity of AF (persistent versus paroxysmal) and AF in different clinical settings (postablation, postcardiac surgery, or postcardioversion). Definitions of epicardial and pericardial fat varied between studies. 11 In subgroup analyses, however, we considered studies to have quantified epicardial fat if they described measurement of adiposity between the myocardium and visceral pericardium. 11 Human studies reporting data in any language were included. Two investigators independently performed the searches and reviewed all identified studies for inclusion. The decision to include studies was hierarchical, initially based on the study title, followed by abstract, and then full-text review of each remaining article.
Data Extraction
Data from included studies were extracted independently by 2 investigators using a standard protocol. Data were extracted (where available and applicable) on study data reported (AF risk, AF severity, postablation AF, postoperative AF, or postcardioversion AF), study characteristics (year, region, and design), adiposity measurement (epicardial fat, WC, WHR, and BMI), epicardial fat type (epicardial fat, pericardial fat, or unspecified), epicardial fat location (total, periatrial, periventricular fat, or unspecified), imaging modality (magnetic resonance imaging [MRI], computed tomography [CT], or echocardiography), epicardial fat measurement method (volume, thickness, or area), number of AF cases, mean and variance of
WHAT IS KNOWN
• Adiposity is an important modifiable risk factor for atrial fibrillation, albeit the underlying mechanisms are not fully understood.
• Epicardial fat has also been linked to atrial fibrillation, but the comparative importance of epicardial fat with other measures of adiposity is not known.
WHAT THE STUDY ADDS
• A meta-analysis of 63 population studies, involving 352 275 individuals, compared the risks of atrial fibrillation for differences in epicardial fat with those for other measures of abdominal and overall adiposity.
• The strength of association of atrial fibrillation with epicardial fat was much greater than those for either abdominal or overall adiposity, highlighting the potential mechanistic and clinical importance of epicardial fat in patients with atrial fibrillation Figure 1 . Profile of included studies. Results of electronic database search leading to study selection. AF indicates atrial fibrillation; BMI, body mass index; WC, waist circumference; and WHR, waist-to-hip ratio. 
Statistical Analysis
Risk estimates and confidence intervals (CI) for the associations of AF with adiposity measures were extracted from each study where available and log-transformed. For each study, the risk estimates from the most fully adjusted models were abstracted. For studies that only reported relative risks (RR) in subgroups, we used fixed-effects meta-analysis to generate an overall study-level RR.
Where mean and variance for group-specific epicardial fat depots were provided instead of risk estimates, standardized mean differences were computed and log-transformed. To facilitate standardized comparisons, risk estimates and their CIs were rescaled to correspond to a 1-SD increase where necessary. Overall summary estimates were subsequently calculated using random-effects meta-analysis. Overall summary RRs are presented with 95% CI; all other RRs are presented with 99% CIs. For primary epicardial fat analyses, we restricted meta-analysis to studies that used either MRI or CT to measure epicardial fat volumes because echocardiography can only measure pericardial separation, not all of which may be adipose tissue, and epicardial fat thickness and area do not necessarily reflect epicardial fat volume. 1 Heterogeneity across studies was quantified using I 2 statistics and was explored using subgroup analyses, sensitivity analyses, and meta-regression techniques. Epicardial fat study characteristics considered as possible sources of heterogeneity included study year, study type, prospective design, study region, imaging modality, measurement method, fat definition, fat location, sample size, publication status, and covariate adjustment. As sensitivity epicardial fat analyses, we tested the effect of (1) including studies that used echocardiography; (2) excluding individual studies; and (3) excluding studies considered to be at higher risk of bias. We screened for small-study effects that might be attributable to publication bias using funnel plots of effect size plotted against SE, Egger test, Begg test; where present, the effect of this was characterized using trim-and-fill procedures. All analyses were performed using Stata 13.0 (Stata Corporation) and R 3.2.1 (R Project), and a 2-tailed value of P<0.05 was considered statistically significant.
Results

Included Studies
The systematic search of electronic databases identified 3146 reports, from which we identified 670 potentially relevant studies for full-text review ( Figure 1 ). An additional 12 studies were identified by manual searching of reference lists. A total of 63 eligible studies, involving 352 725 individuals, were included: 34 on epicardial fat (Table 1), 14-47 5 on WC and WHR (Tables 2 and 3 , respectively), [48] [49] [50] [51] [52] and 24 on BMI (Table 4) . 49, 50, From these studies, 34, 5, 4, and 25 separate risk estimates for associations of AF with epicardial fat, WC, WHR, and BMI, respectively, were available for pooling. Among the 34 epicardial fat studies, 23 studies used CT to quantify epicardial fat depots, 3 used MRI, and 8 used echocardiography. Among these 34 studies, 21 measured volume, 11 measured thickness, and 2 measured area. The primary epicardial fat analysis was restricted to 21 studies involving 16 496 individuals, and the secondary analysis included 13 further studies (that used echocardiography, or measured epicardial fat thickness or area) involving an additional 4286 individuals. 
Associations of Epicardial Fat With the Presence and Severity of AF
The overall pooled summary of 10 separate risk estimates from MRI and CT studies indicated that a 1-SD higher in epicardial fat volume was associated with 2.6-fold higher odds of any AF (odds ratio [OR], 2.61; 95% CI, 1.89-3.60; Figure 2A ). A total of 14 risk estimates from MRI and CT studies were available on the association between epicardial fat volume and the presence of paroxysmal and persistent AF compared with sinus rhythm. A 1-SD higher epicardial fat volume was associated with 2.1-fold higher odds of paroxysmal AF (OR, 2.14; 95% CI, 1.45-3.16) and 5.4-fold higher odds of persistent AF (OR, 5.43; 95% CI, 3.24-9.12; Figure 2C ) compared with sinus rhythm. Eleven risk estimates from MRI and CT studies were available on the association between epicardial fat volume and persistent AF compared with paroxysmal AF. Likewise, a 1-SD higher epicardial fat volume was associated with 2.2-fold higher odds of persistent AF relative to paroxysmal AF (OR, 2.19; 95% CI, 1.68-2.88; Figure 2B ). Heterogeneity was observed in some of the above metaanalyses (I 2 statistics: any AF 80% P<0.001, AF severity 28% P=0.18, postprocedural AF 76% P<0.001). displays the results of subgroup analyses exploring the sources of this heterogeneity, which suggest that this may reflect differences in fat quantification (epicardial or pericardial fat), covariates used for adjustment, study region, and study type. Sensitivity analyses including studies that either used echocardiography or nonvolumetric methods (thickness or area) to quantify epicardial fat resulted in greater heterogeneity and more extreme associations (Table 6 ). Estimates were consistent in other sensitivity analyses excluding individual studies and those studies at higher risk of bias (Tables I through V in the Data Supplement). Although metaregression techniques did not suggest sample size significantly contributed to heterogeneity, funnel plots indicated the presence of small study effects (Figures I through IV in the Data Supplement). Trim and fill methods accounting for these effects attenuated overall estimates although they remained statistically significant.
Associations of Epicardial Fat With Postprocedural AF
A total of 13 postprocedural studies were identified. Among the 11 studies of the association of epicardial fat volume with postablation AF, a 1-SD higher epicardial fat volume was associated with 2.7-fold higher odds of postablation AF (OR, 2.69; 95% CI, 1.66-4.07; Figure 2D ). Two studies assessed the association between epicardial fat and postoperative AF, where a 1-SD higher epicardial fat volume was associated with 2. Figure 2D ). A single study also reported a significant association between epicardial fat thickness and postcardioversion AF (OR, 2.01; 95% CI, 1.15-3.53). Overall, 1-SD higher in epicardial fat volume was associated with 2.5-fold higher odds of any postprocedural AF (OR, 2.49; 95% CI, 1.72-3.49; Figure 2D ).
Heterogeneity was observed in the meta-analysis of postablation AF studies (I 2 statistics: postablation AF 78% P<0.001, postoperative AF 61% P=0.11). Subgroup analyses exploring this heterogeneity suggested that this may be in part because of study region. Sensitivity analyses including studies that either used echocardiography or (Table 6) . Estimates were consistent with other sensitivity analyses excluding individual studies and studies at higher risk of bias (Tables VI through X in the Data Supplement). Metaregression did not suggest sample size significantly contributed to heterogeneity. There was some evidence of small study effects as seen in funnel plot asymmetry, and trim and fill methods accounting for this attenuated overall estimates though they remained significant (Figures V and VI in the Data Supplement).
Associations of Abdominal and Overall Adiposity With AF
Five studies examined the associations between abdominal adiposity with any AF; RRs per 1-SD higher measure were 1.32 (95% CI, 1.25-1.41) for WC and 1.11 (95% CI, 1.08-1.14) for WHR (Figure 3) . From 24 separate risk estimates, a 1-SD higher in BMI was similarly associated with a 1.2-fold greater risk of any AF (RR, 1.22; 95% CI, 1.17-1.27; Figure 4 ). There was heterogeneity in associations of BMI (I 2 statistic 81% P<0.001) but not of WC and WHR (I 2 statistics 34% P=0.20 and 0% P=0.65, respectively).
Discussion Major Findings
This meta-analysis of 63 studies, involving 352 275 individuals, demonstrated strong and graded associations between higher epicardial fat volumes and risk of AF. Importantly, higher epicardial fat volume was also associated with greater severity of AF (persistent compared to paroxysmal AF). Similar associations were observed for postablation, postoperative, and postcardioversion AF. Moreover, all of these associations with epicardial fat were stronger than those for either abdominal or overall adiposity.
Potential Pathogenicity of Epicardial Fat
The epidemiological burden of AF is increasing, and previous reports have estimated that obesity may account for one fifth of cases and 60% of the recent increase in AF cases. [73] [74] [75] [76] [77] In view of the substantial attributable risk of AF because of obesity, the potential role of epicardial fat in mediating the relationships between overall adiposity and AF has prompted considerable interest in this hypothesis. 1, 11, 13 The importance of ectopic fat depots has been previously demonstrated in other cardiometabolic disorders. 78 Such ectopic adipose tissue may have distinct biological properties compared with subcutaneous adiposity, and the unfavorable distribution of Secondary analyses included other studies that used echocardiography or nonvolumetric methods to quantify epicardial fat.
P values are tests for interaction. AF indicates atrial fibrillation; CI, confidence interval; and OR, odds ratio. such fat depots may in part explain the variable cardiometabolic risk seen in individuals with similar degrees of overall adiposity. As with other ectopic adipose tissue, there is growing body of evidence from basic and clinical studies suggesting a role for epicardial fat in arrhythmogenesis. 1, 11, 12 Crucially, the anatomic proximity of the epicardial fat to the adjacent myocardium, given the lack of fascia boundaries, may facilitate pathogenic interaction. Subsequent structural remodeling, similar to that observed in other AF substrates, may create the electric heterogeneity conducive to arrhythmogenesis.
79,80
Epicardial Fat and AF
The increasing recognition of the potential pathogenicity of ectopic fat, together with increased availability of imaging modalities, has prompted further studies to quantify ectopic fat depots and characterize clinically relevant disease associations. In an analysis from the Framingham Heart Study, pericardial fat volume was associated with prevalent AF even after adjusting for AF risk factors, BMI, and other ectopic fat depots. 17 Epicardial fat has also been shown to be associated with increasing AF severity and postablation AF. [14] [15] [16] However, these findings have not been invariably confirmed in other reports. In 1 large prospective cohort, epicardial fat was not associated with incident AF after adjusting for AF risk factors. 26 Likewise, other investigators have not demonstrated significant associations between epicardial fat and paroxysmal AF or postablation AF. 17, 21, 28, 30 Hence, we conducted this meta-analysis to clarify this uncertainty and confirmed an association between increasing epicardial fat and any AF. Furthermore, there was also an association between epicardial fat and increasing AF burden (ie, increasing epicardial fat being associated with the presence of more severe persistent AF compared with paroxysmal AF). This may potentially explain why some individual studies failed to demonstrate significant associations between epicardial fat and the presence of paroxysmal AF compared with sinus rhythm. With greater statistical power than individual studies, our analyses also showed a relationship between epicardial fat and paroxysmal AF although the effect estimate for this relationship was smaller than the association between epicardial fat and persistent AF, consistent with a dose-response relationship between epicardial fat and the increasingly severe continuum from paroxysmal to persistent AF.
Associations were similarly observed between increasing epicardial fat depots and postprocedural AF, including after catheter ablation, cardiac surgery, and electric cardioversion. The consistency of associations across different clinical settings may be supportive of a true arrhythmogenic effect of epicardial fat. Furthermore, these associations seemed to be stronger than those of abdominal and overall adiposity. Taken together, these data support the possibility that epicardial fat may mediate observed associations between overall adiposity and AF.
We have shown previously that intensive risk factor modification and weight reduction may be of benefit in both preventing the development of AF and managing patients with established AF. [81] [82] [83] The increasing clinical availability of imaging modalities, including those undertaken for other indications, may be opportunities to assess epicardial fat depots that could have cardiometabolic implications beyond AF. 78 It is possible that increased epicardial fat could identify patients who may potentially benefit from intensive risk factor modification and weight reduction although this remains to be proven and requires further study. [82] [83] [84] [85] In interpreting the above, many other findings are worthy of discussion. Effect estimates were smaller in studies quantifying pericardial fat compared with those studies measuring epicardial fat. This is consistent with a more biologically plausible effect of the anatomically contiguous epicardial fat, and the inclusion of less relevant paracardial adiposity in studies that measured pericardial fat may be attenuating associations between epicardial fat and AF. Interestingly, epicardial fat associations also seemed to differ by geographic region, with effect estimates in studies from Asia being stronger than those from North America or Europe. Racial differences in body composition are well-established, and individuals of Asian descent have greater cardiovascular morbidity with lower amounts of overall and abdominal adiposity. It may be possible that ectopic adipose tissue has similar race-specific associations with cardiovascular disease although this hypothesis requires further exploration in future studies.
Limitations
The present review had a number of limitations that warrant discussion. We restricted the primary epicardial fat analyses to studies using MRI or CT to measure epicardial fat volume given limitations in echocardiographic and nonvolumetric methods of quantifying epicardial fat outlined previously. Additional sensitivity analyses including studies that used such methods were associated with greater heterogeneity and more extreme estimates of risk. Thus, the present study suggests that volumetric quantification of epicardial fat using CT or MRI may be more reliable for studying disease associations. We explored potential reasons between-study heterogeneity in epicardial fat studies where possible, including that due to fat type, study region, study design, and covariate adjustment (heterogeneity in overall adiposity studies is explored elsewhere). 3 Associations were more extreme in those epicardial fat studies that did not adjust for other risk factors for cardiovascular disease, indicating confounding by other AF risk factors. Although overall epicardial fat summary estimates were attenuated after adjustment for confounding, the associations remained significant in analyses restricted to studies reporting multivariable-adjusted results although we cannot exclude residual confounding by unmeasured variables. We suspect that other between-study variation in epicardial fat quantification that we were unable to characterize may be also in part responsible for heterogeneity. There was also evidence of small study effects, and although trim and fill methods adjusting for these did not materially affect summary estimates, the possibility of publication bias also cannot be eliminated. Given the resource required to image epicardial fat and analyze large data sets for population associations, few included studies had prospective or cohort study designs. Although our findings represent the best-available estimates, future cohort studies are warranted to further evaluate the relative and absolute risks of AF associated with increments in epicardial fat, overall, and in age-specific groups after adjustment for known risk factors for vascular disease, to assess the clinical relevance of these associations. Finally, given the variable definition and use of the terms epicardial and pericardial fat, we also chose to include studies purporting to measure either ectopic fat depot. Any true effect is likely to be because of the more biologically plausible epicardial fat though, and sensitivity analyses in the present report support this suggestion. However, these observational studies cannot exclude the possibility that epicardial fat is merely a marker of AF rather than of being causal.
Conclusions
The present meta-analysis demonstrated significant and graded associations between increasing epicardial fat and AF in multiple clinical settings. The associations seemed stronger than those of abdominal and overall adiposity with AF. Recognizing the importance of epicardial fat as source of adipokines and cytokines, the results of this meta-analysis support the possibility that epicardial fat may mediate the relationships between overall adiposity and arrhythmogenesis. Further studies are needed to assess causality, potential mechanisms, and the relevance and use of epicardial fat measurement in clinical practice. 
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